- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00996853
Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom (H1N1 PASS UK)
Post-Authorization Safety Study (PASS) of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK2340272A) in the United Kingdom (UK)
The focus of this study is to assess the safety of GSK's H1N1 vaccine in real life conditions as soon as the vaccine is used, in a mass vaccination programme, and with a system for rapid generation, communication and evaluation of safety data.
This study is a commitment to the European Medicines Agency (EMEA), as part of GlaxoSmithKline Biologicals' (GSK Biologicals') risk management plan for pandemic influenza vaccination.
Descripción general del estudio
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Addlestone,Surrey, Reino Unido, KT15 2BH
- GSK Investigational Site
-
Attleborough, Norfolk, Reino Unido, NR17 2AS
- GSK Investigational Site
-
Axbridge, Somerset, Reino Unido, BS26 2BJ
- GSK Investigational Site
-
Baldock, Herts, Reino Unido, SG7 6BP
- GSK Investigational Site
-
Balham, London, Reino Unido, SW12 8WU
- GSK Investigational Site
-
Bath, Avon, Reino Unido, BA2 4JT
- GSK Investigational Site
-
Bath, Somerset, Reino Unido, BA2 4BY
- GSK Investigational Site
-
Bedwell Crescent, Stevenage, Reino Unido, SG1 1LQ
- GSK Investigational Site
-
Blenheim Walk, Leeds, Reino Unido, LS2 9AE
- GSK Investigational Site
-
Botesdale, Reino Unido, IP22 1DW
- GSK Investigational Site
-
Boughton, King's Lynn, Reino Unido, PE33 9AG
- GSK Investigational Site
-
Bristol, Avon, Reino Unido, BS13 8LD
- GSK Investigational Site
-
Bromsgrove,Worcestershire, Reino Unido, B61 8DT
- GSK Investigational Site
-
Chard, Somerset, Reino Unido, TA20 1QF
- GSK Investigational Site
-
Chesterfield, Reino Unido, S41 8NA
- GSK Investigational Site
-
Colchester,Essex, Reino Unido, CO4 9YN
- GSK Investigational Site
-
Comberton,Cambridge, Reino Unido, CB23 7DY
- GSK Investigational Site
-
Darlington, Co. Durham, Reino Unido, DL3 8SQ
- GSK Investigational Site
-
Devon, Reino Unido, EX9 6LS
- GSK Investigational Site
-
Didcot,Oxfordshire, Reino Unido, OX11 7JH
- GSK Investigational Site
-
Doncaster, Reino Unido, DN9 1EP
- GSK Investigational Site
-
Ecclesfield, Reino Unido, S35 9XQ
- GSK Investigational Site
-
Ellesmere Port,Cheshire, Reino Unido, CH66 2WW
- GSK Investigational Site
-
Escrick, York, Reino Unido, YO19 6LE
- GSK Investigational Site
-
Essex, Reino Unido, CO3 4LN
- GSK Investigational Site
-
Fleetwood, Reino Unido, FY7 6HD
- GSK Investigational Site
-
Gosport, Reino Unido, PO12 3AQ
- GSK Investigational Site
-
Hanworth, Feltham, Reino Unido, TW13 6HD
- GSK Investigational Site
-
Harrogate, Reino Unido, HG3 5AT
- GSK Investigational Site
-
Harwood, Bolton, Reino Unido, BL2 3HQ
- GSK Investigational Site
-
Hertfordshire, Reino Unido, SG6 4TS
- GSK Investigational Site
-
High Kelling,Holt,Norfolk, Reino Unido, NR25 6QA
- GSK Investigational Site
-
Honiton,Devon, Reino Unido, EX14 2NY
- GSK Investigational Site
-
Hoyland, Barnsley, Reino Unido, S74 9AF
- GSK Investigational Site
-
Hurstpierpoint, West Sussex, Reino Unido, BN6 9UQ
- GSK Investigational Site
-
Kent, Sevenoaks, Reino Unido, TN13 3NT
- GSK Investigational Site
-
Kettering,Kettering, Reino Unido, NN14 1SN
- GSK Investigational Site
-
Kippax,Leeds, Reino Unido, LS25 7JN
- GSK Investigational Site
-
Lambeth, London, Reino Unido, SW16 5LS
- GSK Investigational Site
-
Lancashire, Reino Unido, BL1 6AP
- GSK Investigational Site
-
Lancaster, Reino Unido, LA1 1RP
- GSK Investigational Site
-
Langport, Somerset, Reino Unido, TA10 9RH
- GSK Investigational Site
-
Leicester, Reino Unido, LE4 0UZ
- GSK Investigational Site
-
Lichfield, Reino Unido, WS13 6JL
- GSK Investigational Site
-
London, Reino Unido, NW3 1NR
- GSK Investigational Site
-
London, Reino Unido, SE11 6SP
- GSK Investigational Site
-
London, Reino Unido, W11 1PA
- GSK Investigational Site
-
Lutterworth, Leicestershire, Reino Unido, LE17 4EB
- GSK Investigational Site
-
Mossley, Ashton Under Lyne, Reino Unido, OL5 0HE
- GSK Investigational Site
-
Nantwich, Cheshire, Reino Unido, CW5 5NX
- GSK Investigational Site
-
Norwich, Norfolk, Reino Unido, NR12 8DU
- GSK Investigational Site
-
Norwich, Norfolk, Reino Unido, NR3 2HW
- GSK Investigational Site
-
Nottingham, Reino Unido, NG7 2QW
- GSK Investigational Site
-
Orton Goldhay, Peterborough, Reino Unido, PE2 5GP
- GSK Investigational Site
-
Oxfordshire, Reino Unido, OX12 9BN
- GSK Investigational Site
-
Paiginton, Devon, Reino Unido, TQ3 3TB
- GSK Investigational Site
-
Radstock, Bath, Reino Unido, BA3 2UH
- GSK Investigational Site
-
Romsey, Hampshire, Reino Unido, SO517QN
- GSK Investigational Site
-
Rowlands Castle, Reino Unido, PO9 6BN
- GSK Investigational Site
-
Ruislip, Reino Unido, HA4 6ER
- GSK Investigational Site
-
Runcorn, Cheshire, Reino Unido, WA7 1AB
- GSK Investigational Site
-
Salisbury, Hampshire, Reino Unido, SP1 1DX
- GSK Investigational Site
-
Sedgefield, Reino Unido, TS21 3BN
- GSK Investigational Site
-
Shipston-on-Stour, Warwickshire, Reino Unido, CV36 4BQ
- GSK Investigational Site
-
Somerset, Reino Unido, TA18 8BX
- GSK Investigational Site
-
Southbourne, Hampshire, Reino Unido, PO10 8JH
- GSK Investigational Site
-
Southsea, Hampshire, Reino Unido, P05 3ND
- GSK Investigational Site
-
Stowmarket,Suffolk, Reino Unido, IP14 1NL
- GSK Investigational Site
-
Sunderland, Reino Unido, SR3 4HG
- GSK Investigational Site
-
Sway, Hampshire, Reino Unido, S041 6BA
- GSK Investigational Site
-
Swindon, Wiltshire, Reino Unido, SN25 1QQ
- GSK Investigational Site
-
Tadworth,Surrey, Reino Unido, KT20 5JE
- GSK Investigational Site
-
Tarporley,Cheshire, Reino Unido, CW6 0BE
- GSK Investigational Site
-
Thornbury, Bristol, Reino Unido, BS35 1DP
- GSK Investigational Site
-
Wandsford, Peterborough, Reino Unido, PE8 6PL
- GSK Investigational Site
-
Wantage, Reino Unido, OX12 9BN
- GSK Investigational Site
-
Wantage, Oxon, Reino Unido, OX12 9BN
- GSK Investigational Site
-
Western Approach,Plymouth, Reino Unido, PL1 5AJ
- GSK Investigational Site
-
Westhoughton, Bolton, Reino Unido, BL5 3UB
- GSK Investigational Site
-
Wiltshire, Reino Unido, SN10 4AQ
- GSK Investigational Site
-
Wiltshire, Westbury, Reino Unido, BA13 3JD
- GSK Investigational Site
-
Windemere,Cumbria, Reino Unido, LA23 2EG
- GSK Investigational Site
-
Wokingham, Berkshire, Reino Unido, RG41 3DR
- GSK Investigational Site
-
York, Reino Unido, YO24 4HD
- GSK Investigational Site
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Reino Unido, CB3 9HS
- GSK Investigational Site
-
-
Hertfordshire
-
Watford, Hertfordshire, Reino Unido, WD25 0EA
- GSK Investigational Site
-
-
Kent
-
Canterbury, Kent, Reino Unido, CT1 3HX
- GSK Investigational Site
-
-
Lancashire
-
Blackburn, Lancashire, Reino Unido, BB2 2ST
- GSK Investigational Site
-
-
Northamptonshire
-
Wellingborough, Northamptonshire, Reino Unido, NN8 4RW
- GSK Investigational Site
-
-
Somerset
-
Bath, Somerset, Reino Unido, BA2 1NH
- GSK Investigational Site
-
Frome, Somerset, Reino Unido, BA11 1EZ
- GSK Investigational Site
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Written informed consent, and assent where appropriate, obtained from the subject/from the subject's parent(s)/ Legally Acceptable Representative(s) (LAR).
- A male or female subject vaccinated with a first dose of GSK Biologicals' H1N1 pandemic influenza vaccine
- shortly (<24h) before being recruited in the study, and
- within a GP practice participating in the study and where the subject is registered.
- Subjects who the Investigator believes that they and/or their parent(s)/LAR can and will comply with the requirements of the protocol
Exclusion Criteria:
- Subjects already vaccinated with any other H1N1 pandemic vaccine before study enrolment.
- Child in care
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
---|---|
Total vaccinated cohort
The Total vaccinated cohort will include all subjects with at least one vaccine administration documented.
|
Collection of reactogenicity data from diary cards, reporting of medically-attended adverse events, reporting of serious adverse events and adverse events of special interest, reporting of pregnancy outcomes and fatalities.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Medically-attended adverse events
Periodo de tiempo: Within one month after any dose
|
Within one month after any dose
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
---|---|
Adverse events solicited to assess reactogenicity
Periodo de tiempo: Within seven days after any dose
|
Within seven days after any dose
|
Serious adverse events and adverse events of special interest
Periodo de tiempo: Within six months after the second vaccine dose or within a maximum of eight months after the first dose
|
Within six months after the second vaccine dose or within a maximum of eight months after the first dose
|
Pregnancy outcomes
Periodo de tiempo: Within two months after vaccination (last menstrual period up to 45 days after any dose)
|
Within two months after vaccination (last menstrual period up to 45 days after any dose)
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Nazareth I, Tavares F, Rosillon D, Haguinet F, Bauchau V. Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study. BMJ Open. 2013 Feb 5;3(2):e001912. doi: 10.1136/bmjopen-2012-001912. Print 2013. Erratum In: BMJ Open. 2013 Feb 19;3(2):null.
- Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine. 2011 Aug 26;29(37):6358-65. doi: 10.1016/j.vaccine.2011.04.114. Epub 2011 May 17.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 113585
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Safety follow up
-
Cambridge Health AllianceReclutamientoTrastornos del Comportamiento | Trastornos mentales graves | Trastornos emocionalesEstados Unidos
-
Johns Hopkins UniversityAmerican SIDS InstituteAún no reclutandoMuerte Súbita Infantil
-
Medtronic - MITGReclutamientoInsuficiencia renal en etapa terminal en diálisisEstados Unidos
-
Shannon E. Sauer-ZavalaTerminadoDesorden depresivo | Desorden obsesivo compulsivo | Desórdenes de ansiedad | Trastorno de estrés postraumáticoEstados Unidos
-
Shannon E. Sauer-ZavalaNational Institute of Mental Health (NIMH)Activo, no reclutandoDesorden obsesivo compulsivo | Desórdenes de ansiedad | Trastorno de estrés postraumáticoEstados Unidos
-
University of MichiganNational Institute on Drug Abuse (NIDA); Brown University; Pennington Biomedical... y otros colaboradoresReclutamiento
-
Asklepios Kliniken Hamburg GmbHUniversity of KielTerminadoGestión de las vías respiratorias | Vía aérea con máscara laríngea | Intubación de fibra óptica
-
University of South FloridaTemple University; National Institute on Disability, Independent Living, and... y otros colaboradoresReclutamientoEnfermedad mental | Trastornos del Comportamiento | Diagnóstico psiquiátrico | Desórdenes psiquiátricos | Enfermedad mental grave | Enfermedades psiquiátricas | Enfermedad psiquiátricaEstados Unidos
-
University of California, Los AngelesDuke UniversityReclutamientoIdeación suicidaEstados Unidos
-
University of California, Los AngelesPatient-Centered Outcomes Research Institute; Brown University; Duke University; University... y otros colaboradoresReclutamientoSuicidio y autoagresiónEstados Unidos